Placebo-Controlled Trial of Once-A-Day Isradipine Monotherapy in Mild to Moderately Severe Hypertension
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1990.tb03587.x/fullpdf
Reference34 articles.
1. Maximally reducing cardiovascular risk in the treatment of hypertension;Kaplan;Ann Intern Med,1988
2. Effects of calcium channel blockers on systemic hemodynamics in hypertension;Messerli;Am J Med,1988
3. Vasodilator drugs in the treatment of hypertension;Koch-Weser;Arch intern Med,1974
4. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension;Winer;Clin Pharmacol Ther,1987
5. Comparison of isradipine and diltiazem in the treatment of essential hypertension;Vermeulen;Am J Med,1988
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discontinuation of Antihypertensive Drugs Due to Adverse Events: A Systematic Review and Meta-analysis;Pharmacotherapy;2001-08
2. Risk of serious adverse events in hypertensive patients receiving isradipine: a meta-analysis;Journal of Human Hypertension;1997-11
3. Sustained Blood Pressure Control with Controlled-Release Isradipine (Isradipine-CR);The Journal of Clinical Pharmacology;1995-03
4. Isradipine—Another Calcium-Channel Blocker for the Treatment of Hypertension and Angina;Annals of Pharmacotherapy;1992-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3